290 related articles for article (PubMed ID: 33328263)
1. COVID-19 mortality effects of underlying health conditions in India: a modelling study.
Novosad P; Jain R; Campion A; Asher S
BMJ Open; 2020 Dec; 10(12):e043165. PubMed ID: 33328263
[TBL] [Abstract][Full Text] [Related]
2. The interaction between district-level development and individual-level socioeconomic gradients of cardiovascular disease risk factors in India: A cross-sectional study of 2.4 million adults.
Jung L; De Neve JW; Chen S; Manne-Goehler J; Jaacks LM; Corsi DJ; Awasthi A; Subramanian SV; Vollmer S; Bärnighausen T; Geldsetzer P
Soc Sci Med; 2019 Oct; 239():112514. PubMed ID: 31541939
[TBL] [Abstract][Full Text] [Related]
3. Country-level determinants of the severity of the first global wave of the COVID-19 pandemic: an ecological study.
Pana TA; Bhattacharya S; Gamble DT; Pasdar Z; Szlachetka WA; Perdomo-Lampignano JA; Ewers KD; McLernon DJ; Myint PK
BMJ Open; 2021 Feb; 11(2):e042034. PubMed ID: 33536319
[TBL] [Abstract][Full Text] [Related]
4. Socioeconomic Gradients and Distribution of Diabetes, Hypertension, and Obesity in India.
Corsi DJ; Subramanian SV
JAMA Netw Open; 2019 Apr; 2(4):e190411. PubMed ID: 30951154
[TBL] [Abstract][Full Text] [Related]
5. Detrimental effect of diabetes and hypertension on the severity and mortality of COVID-19 infection: A multi-center case-control study from India.
Jayaswal SK; Singh S; Malik PS; Venigalla SK; Gupta P; Samaga SN; Hota RN; Bhatia SS; Gupta I
Diabetes Metab Syndr; 2021; 15(5):102248. PubMed ID: 34412000
[TBL] [Abstract][Full Text] [Related]
6. Determinants of survival after severe acute respiratory syndrome coronavirus 2 infection in Mexican outpatients and hospitalised patients.
Prado-Galbarro FJ; Sanchez-Piedra C; Gamiño-Arroyo AE; Cruz-Cruz C
Public Health; 2020 Dec; 189():66-72. PubMed ID: 33166857
[TBL] [Abstract][Full Text] [Related]
7. Time trends in adult chronic disease inequalities by education in Brazil: 1998-2013.
Beltrán-Sánchez H; Andrade FC
Int J Equity Health; 2016 Nov; 15(1):139. PubMed ID: 27852329
[TBL] [Abstract][Full Text] [Related]
8. Analysis of Risk Factors in COVID-19 Adult Mortality in Russia.
Kirillov Y; Timofeev S; Avdalyan A; Nikolenko VN; Gridin L; Sinelnikov MY
J Prim Care Community Health; 2021; 12():21501327211008050. PubMed ID: 33829916
[TBL] [Abstract][Full Text] [Related]
9. The Prevalence of Overweight, Obesity, Hypertension, and Diabetes in India: Analysis of the 2015-2016 National Family Health Survey.
Vennu V; Abdulrahman TA; Bindawas SM
Int J Environ Res Public Health; 2019 Oct; 16(20):. PubMed ID: 31635366
[TBL] [Abstract][Full Text] [Related]
10. High prevalence of diabetes and other comorbidities in hospitalized patients with COVID-19 in Delhi, India, and their association with outcomes.
Mithal A; Jevalikar G; Sharma R; Singh A; Farooqui KJ; Mahendru S; Krishnamurthy A; Dewan A; Budhiraja S
Diabetes Metab Syndr; 2021; 15(1):169-175. PubMed ID: 33360081
[TBL] [Abstract][Full Text] [Related]
11. Health and Institutional Risk Factors of COVID-19 Mortality in Mexico, 2020.
Najera H; Ortega-Avila AG
Am J Prev Med; 2021 Apr; 60(4):471-477. PubMed ID: 33745520
[TBL] [Abstract][Full Text] [Related]
12. Diabetes mellitus and mortality from all-causes, cancer, cardiovascular and respiratory disease: evidence from the Health Survey for England and Scottish Health Survey cohorts.
Gordon-Dseagu VL; Shelton N; Mindell J
J Diabetes Complications; 2014; 28(6):791-7. PubMed ID: 25104237
[TBL] [Abstract][Full Text] [Related]
13. Small Area Geographic Estimates of Cardiovascular Disease Risk Factors in India.
Ko S; Oh H; Subramanian SV; Kim R
JAMA Netw Open; 2023 Oct; 6(10):e2337171. PubMed ID: 37824144
[TBL] [Abstract][Full Text] [Related]
14. Diabetes and covid-19: more than the sum of two morbidities.
Pititto BA; Ferreira SRG
Rev Saude Publica; 2020; 54():54. PubMed ID: 32491053
[TBL] [Abstract][Full Text] [Related]
15. Obesity during the COVID-19 pandemic: both cause of high risk and potential effect of lockdown? A population-based electronic health record study.
Katsoulis M; Pasea L; Lai AG; Dobson RJB; Denaxas S; Hemingway H; Banerjee A
Public Health; 2021 Feb; 191():41-47. PubMed ID: 33497994
[TBL] [Abstract][Full Text] [Related]
16. Association between obesity and diabetes prevalence and COVID-19 mortality in Mexico: an ecological study.
Noyola DE; Hermosillo-Arredondo N; Ramírez-Juárez C; Werge-Sánchez A
J Infect Dev Ctries; 2021 Oct; 15(10):1396-1403. PubMed ID: 34780361
[TBL] [Abstract][Full Text] [Related]
17. Estimated County-Level Prevalence of Selected Underlying Medical Conditions Associated with Increased Risk for Severe COVID-19 Illness - United States, 2018.
Razzaghi H; Wang Y; Lu H; Marshall KE; Dowling NF; Paz-Bailey G; Twentyman ER; Peacock G; Greenlund KJ
MMWR Morb Mortal Wkly Rep; 2020 Jul; 69(29):945-950. PubMed ID: 32701937
[TBL] [Abstract][Full Text] [Related]
18. Socioeconomic and demographic predictors of high blood pressure, diabetes, asthma and heart disease among adults engaged in various occupations: evidence from India.
Patel S; Ram U; Ram F; Patel SK
J Biosoc Sci; 2020 Sep; 52(5):629-649. PubMed ID: 31647045
[TBL] [Abstract][Full Text] [Related]
19. Hypertension, Diabetes and Obesity, Major Risk Factors for Death in Patients with COVID-19 in Mexico.
Peña JE; Rascón-Pacheco RA; Ascencio-Montiel IJ; González-Figueroa E; Fernández-Gárate JE; Medina-Gómez OS; Borja-Bustamante P; Santillán-Oropeza JA; Borja-Aburto VH
Arch Med Res; 2021 May; 52(4):443-449. PubMed ID: 33380361
[TBL] [Abstract][Full Text] [Related]
20. Estimation of case-fatality rate in COVID-19 patients with hypertension and diabetes mellitus in the New York state: a preliminary report.
Ge Y; Sun S; Shen Y
Epidemiol Infect; 2021 Jan; 149():e14. PubMed ID: 33413720
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
